dr. shuch on the impact of the surtime trial in advanced rcc
Published 5 years ago • 237 plays • Length 2:15Download video MP4
Download video MP3
Similar videos
-
1:50
dr. shuch on role of cytoreductive nephrectomy in rcc
-
1:59
dr. shuch on considerations for appropriate treatment in advanced rcc
-
1:37
dr. shuch on caveats of avelumab/axitinib combination in rcc
-
1:05
dr. shuch on biology of non-clear cell rcc
-
1:47
dr. choueiri on the impact of the javelin renal 101 findings in rcc
-
2:06
dr. choueiri on frontline trials of immunotherapy in rcc
-
25:16
what is the role for cytoreductive surgery in the treatment of metastatic renal cell carcinoma?
-
4:30
surgeon performed ultrasound (spus) of the thyroid gland
-
28:12
avoiding unnecessary treatment of the small renal mass | brian shuch, md | uclamdchat
-
1:15:50
differential of renal neoplasms including more recently described entities
-
1:26
dr linscott on future directions for utdna research in bladder cancer
-
2:30
dr. choueiri on the subgroup analysis of the javelin renal 101 trial in rcc
-
1:14
dr. van veldhuizen reflects on the carmena trial in rcc
-
1:14
dr. wysock on the role of cytoreductive nephrectomy in rcc
-
8:43
optimizing the upfront treatment of metastatic renal cell carcinoma
-
0:52
dr. choueiri on impact of cabosun results in renal cell carcinoma
-
4:22
disease progression in patients with metastatic rcc
-
3:47
other clinical trials in renal cell carcinoma
-
8:11
implications of using adjuvant sorafenib and sunitinib in unfavourable renal carcinoma
-
8:57
introduction and review of the comparz trial in renal cell carcinoma
-
1:05:38
watch drs. choueiri, mcdermott, and tannir, discuss the latest in rcc: https://bit.ly/3n3x59m
-
2:11
dr. haas on adjuvant sorafenib or sunitinib for rcc